NeuroVive Pharmaceutical AB: Catharina Johansson Appointed New CFO, Effective 1 December
Published: Oct 09, 2013
NeuroVive Pharmaceutical AB (publ)(STO:NVP), a leading mitochondrial medicine company, has appointed Catharina Johansson as the company’s new CFO. She will take up her position on 1 December. This appointment concludes the recruitment process initiated earlier this year when the company’s previous CFO, Christian Svensson, announced his decision to step down, to focus on his own consulting practice.
Help employers find you! Check out all the jobs and post your resume.